ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Tops Revenue Estimates

ClearPoint Neuro, Inc. (CLPT) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of$ 0.19. This compares to loss of $0.29 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 15.79%. A quarter ago, it was expected that this company would post a loss of$ 0.19 per share when it actually produced a loss of $0.16, delivering a surprise of 15.79%. Over the last four quarters, the company has ...